Viser: Immunotherapy in Translational Cancer Research

Immunotherapy in Translational Cancer Research, 1. udgave
Søgbar e-bog

Immunotherapy in Translational Cancer Research Vital Source e-bog

Laurence J. N. Cooper, Elizabeth A. Mittendorf, Judy Moyes og Sabitha Prabhakaran
(2018)
John Wiley & Sons
2.050,00 kr.
Leveres umiddelbart efter køb
Immunotherapy in Translational Cancer Research

Immunotherapy in Translational Cancer Research

Laurence J. N. Cooper, Elizabeth A. Mittendorf, Judy Moyes og Sabitha Prabhakaran
(2018)
Sprog: Engelsk
John Wiley & Sons, Limited
2.099,00 kr.
ikke på lager, Bestil nu og få den leveret
om ca. 10 hverdage

Detaljer om varen

  • 1. Udgave
  • Vital Source searchable e-book (Reflowable pages)
  • Udgiver: John Wiley & Sons (Februar 2018)
  • Forfattere: Laurence J. N. Cooper, Elizabeth A. Mittendorf, Judy Moyes og Sabitha Prabhakaran
  • ISBN: 9781118684528
A guide to state-of-the-art cancer immunotherapy in translational cancer research  A volume in the Translational Oncology series, Immunotherapy in Translational Cancer Research explores the recent developments in the role that immunotherapy plays in the treatment of a wide range of cancers. The editors present key concepts, illustrative examples, and suggest alternative strategies in order to achieve individualized targeted therapy. Comprehensive in scope, Immunotherapy in Translational Cancer Research reviews the relevant history, current state, and the future of burgeoning cancer-fighting therapies. The book also includes critical information on drug development, clinical trials, and governmental resources and regulatory issues. Each chapter is created to feature: development of the immunotherapy; challenges that have been overcome in order to scale up and undertake clinical trials; and clinical experience and application of research. This authoritative volume is edited by a team of noted experts from MD Anderson Cancer Center, the world’s foremost cancer research and care center and:  Offers a comprehensive presentation of state-of-the-art cancer immunotherapy research that accelerates the pace of clinical cancer care  Filled with the concepts, examples, and approaches for developing individualized therapy Explores the breath of treatments that reflect the complexity of the immune system itself Includes contributions from a panel international experts in the field of immunotherapy Designed for physicians, medical students, scientists, pharmaceutical executives, public health and public policy government leaders and community oncologists, this essential resource offers a guide to the bidirectional interaction between laboratory and clinic immunotherapy cancer research.
Licens varighed:
Bookshelf online: 5 år fra købsdato.
Bookshelf appen: ubegrænset dage fra købsdato.

Udgiveren oplyser at følgende begrænsninger er gældende for dette produkt:
Print: 10 sider kan printes ad gangen
Copy: højest 2 sider i alt kan kopieres (copy/paste)

Detaljer om varen

  • Hardback: 312 sider
  • Udgiver: John Wiley & Sons, Limited (April 2018)
  • Forfattere: Laurence J. N. Cooper, Elizabeth A. Mittendorf, Judy Moyes og Sabitha Prabhakaran
  • ISBN: 9781118123225

A guide to state-of-the-art cancer immunotherapy in translational cancer research 

A volume in the Translational Oncology series, Immunotherapy in Translational Cancer Research explores the recent developments in the role that immunotherapy plays in the treatment of a wide range of cancers. The editors present key concepts, illustrative examples, and suggest alternative strategies in order to achieve individualized targeted therapy. Comprehensive in scope, Immunotherapy in Translational Cancer Research reviews the relevant history, current state, and the future of burgeoning cancer-fighting therapies. The book also includes critical information on drug development, clinical trials, and governmental resources and regulatory issues.

Each chapter is created to feature: development of the immunotherapy; challenges that have been overcome in order to scale up and undertake clinical trials; and clinical experience and application of research. This authoritative volume is edited by a team of noted experts from MD Anderson Cancer Center, the world's foremost cancer research and care center and: 

  • Offers a comprehensive presentation of state-of-the-art cancer immunotherapy research that accelerates the pace of clinical cancer care 
  • Filled with the concepts, examples, and approaches for developing individualized therapy
  • Explores the breath of treatments that reflect the complexity of the immune system itself
  • Includes contributions from a panel international experts in the field of immunotherapy

Designed for physicians, medical students, scientists, pharmaceutical executives, public health and public policy government leaders and community oncologists, this essential resource offers a guide to the bidirectional interaction between laboratory and clinic immunotherapy cancer research.

Editors vi Contributors vii Introduction ix 1 Translation in Immunology: The Role of Translational Biomarkers to Guide Clinical Use of Immunotherapy for Cancer 1 Saranya Chumsri and Keith L. Knutson 2 Monoclonal Antibody Therapy 12 Elizabeth A. Mittendorf and Sabitha Prabhakaran 3 Somatic Mutations and Immunotherapy 24 Eric Tran 4 Checkpoint Blockade 37 Tracy A. ProverbsSingh Jedd Wolchok and Alexandra Snyder 5 Myeloid Leukemia Vaccines 54 Paul M. Armistead and Jonathan S. Serody 6 Cancer Vaccines for Solid Tumors 72 Timothy J. Vreeland Garth S. Herbert and George E. Peoples 7 Immunotherapy with Non-Genetically Modified T Cells 91 Cassian Yee 8 Immunotherapy with Genetically Modified T Cells 101 Liora Schultz and Crystal Mackall 9 Immunomodulation with Adjuvants and Cytokines 115 Dae won Kim and Adi Diab 10 Immune Cell Migration in Cancer and Immunotherapy 132 Timothy Murray and Daniel E. Speiser 11 Repurposing of Drugs for Immunotherapy 143 Jyothishmathi Swaminathan and Vidya Gopalakrishnan 12 Immunomodulation with Radiation 161 Jonathan E. Schoenhals Taylor R. Cushman, Alexandra P. Cadena Sandra Demaria and James W. Welsh 13 Good Manufacturing Practices Facilities for Cellular Therapy 177 Andrew D. Fesnak and Bruce L. Levine 14 T Cell Receptor Mimic Antibodies 186 Gheath Alatrash and Jeffrey J. Molldrem 15 Stem Cell Transplantation for Treatment of Malignancy 201 Lohith S. Bachegowda and Richard E. Champlin 16 Natural Killer Cell-Based Immunotherapy 215 Jennifer A. Foltz Jeffrey S. Miller and Dean A. Lee 17 Immunologic Monitoring in ImmunoOncology 228 William R. Gwin and Mary L. Disis 18 CellBased Therapies for Canine Cancer 252 Nicola J. Mason and M. Kazim Panjwani 19 Interaction between Targeted Therapy and Immunotherapy 268 Peter A. Prieto Miles C. Andrews, Alexandria P. Cogdill, and Jennifer A. Wargo Index 286

B2B service

If you have questions regarding the purchasing of books, the use of this site or our service offers in general, please contact us on poly@polyteknisk.dk

 

Best regards

Polyteknisk B2B service

By agreement with